VENUS REMEDIES
|
The Current P/E Ratio of VENUS REMEDIES is 15.16.
Share Price | ₹513.0 | Jul 28,2025 |
Market Cap | ₹687.4 Cr | |
Earnings-TTM | ₹45.3 Cr | TTM-Consolidated Results |
Price/Earnings | 15.16x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of VENUS REMEDIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹687.4 Cr] as on Jul 28,2025
(/) Earnings [ ₹45.3 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 15.16x ]
Thus, for VENUS REMEDIES , the investors are currently willing to pay 15.16 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of VENUS REMEDIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of VENUS REMEDIES over the last five years.
Historical PE (Price/Earnings) ratio chart of VENUS REMEDIES
PE Ratio Performance Analysis for VENUS REMEDIES
- VENUS REMEDIES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 9.32x.
- VENUS REMEDIES 's operated at median p/e ratio of 8.82x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, VENUS REMEDIES 's p/e ratio peaked in Mar2024 at 15.31x.
- VENUS REMEDIES 's p/e ratio hit its five-year low in Mar2021 of 5.49x.
How does VENUS REMEDIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
VENUS REMEDIES | 45.33 | 15.16 | 687.4 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,980.10 | 37.21 | 408,595.0 |
DIVIS LABORATORIES LTD | 2,191.00 | 79.71 | 174,635.0 |
CIPLA LTD | 5,406.81 | 23.47 | 126,894.0 |
TORRENT PHARMACEUTICALS LTD | 2,002.00 | 61.28 | 122,685.0 |
DR REDDYS LABORATORIES LTD | 5,726.70 | 18.75 | 107,373.0 |
MANKIND PHARMA LTD | 2,003.22 | 52.36 | 104,885.0 |
ZYDUS LIFESCIENCES LTD | 4,614.80 | 21.35 | 98,535.5 |
LUPIN LTD | 3,306.26 | 27.08 | 89,543.0 |
AUROBINDO PHARMA LTD | 3,515.26 | 18.63 | 65,485.4 |
ABBOTT INDIA LTD | 1,414.44 | 49.41 | 69,881.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs VENUS REMEDIES 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 15.16x |
Max industry PE | 79.71x |
Median industry PE | 27.08x |
Average industry PE | 36.76x |
You may also like the below Video Courses